Ask Warren

Bistos

419540 · KOSDAQ · ₩419540 · 비스토스

₩2,590▲ ₩60 (2.37%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −64.76%
Market cap
₩15B
Enterprise value
₩12B
P/E
—
P/B
0.8×
Dividend yield
0.0%
ROE
−6.3%
Net margin
−7.8%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−77.5% from the high

₩2,280Today: ₩2,410 – ₩2,660₩11,500

Returns

  • 1W−4.4%
  • 1M−15.8%
  • 3M+7.5%
  • 6M−39.5%
  • YTD−51.6%
  • 1Y−64.8%
Volume today
10,596
0.5× the 20-day average
Traded today
₩27M
Listed shares
5,958,253
EPS (12 months)
−₩210
Earnings yield −8.1%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

33Quiet
  • BuzzQuietBuzz 33 of 100 (50 is a normal day for this stock).
  • MomentumWeak-17.3% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Bistos stock overview

Bistos (비스토스, KRX: 419540) is listed on KOSDAQ, in the Medical & precision devices sector. The company, founded in 2001 in South Korea, makes biosignal diagnostic and therapeutic medical devices, with a focus on fetal and neonatal equipment such as fetal monitors, infant incubators, warmers and jaundice treatment units. Its shares closed at ₩2,590 on Oct 27, 2026, up 2.37% on the day, giving it a market value of ₩15B.

Key facts

Market cap
₩15B
Sector
Medical & precision devices
Latest price change
+2.37%
As of
Oct 27, 2026
Main business
The company, founded in 2001 in South Korea, makes biosignal diagnostic and therapeutic medical devices, with a focus on fetal and neonatal equipment such as fetal monitors, infant incubators, warmers and jaundice treatment units.

Quick answers about Bistos

What does Bistos do?
The company, founded in 2001 in South Korea, makes biosignal diagnostic and therapeutic medical devices, with a focus on fetal and neonatal equipment such as fetal monitors, infant incubators, warmers and jaundice treatment units. It also sells home-use devices like breast pumps and thermometers, patient monitors, and brain-related and wearable healthcare products. Over 90% of its sales come from exports to roughly 120 countries.
What is the market cap of Bistos?
The market capitalisation of Bistos was ₩15B at the close on Oct 27, 2026.
Who are the largest shareholders of Bistos?
According to the latest official filings, the largest reported holders are CU Medical (49.91%, as of Aug 20, 2026); Sangsangin Savings Bank (8.36%, as of Aug 10, 2026); Lee Hoo-jung (4.38%, as of Jan 21, 2026).
When is the next earnings report from Bistos?
Korean companies rarely announce results dates in advance. Based on when Bistos filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.

Company profile

The company, founded in 2001 in South Korea, makes biosignal diagnostic and therapeutic medical devices, with a focus on fetal and neonatal equipment such as fetal monitors, infant incubators, warmers and jaundice treatment units. It also sells home-use devices like breast pumps and thermometers, patient monitors, and brain-related and wearable healthcare products. Over 90% of its sales come from exports to roughly 120 countries.

Written by AI from the company's latest annual report.

Korean name
비스토스
Sector
Medical & precision devices
Themes
Medical devices
CEO
이선종
Founded
Aug 2001
Listed
Oct 2022
Listed shares
5,958,253
Fiscal year ends
Month 12
Website
www.bistos.co.kr/korean

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Bistos / 비스토스 / 419540 / KRX:419540

Source: KRX statistical information